Meet Fortrea's respiratory experts at the 8th Annual IPF Summit in Boston! Mark Dowling and Veerle Van De Velde will be speaking on July 26, at 2:45. Don't miss the industry’s largest drug development initiative for the pulmonary fibrosis community. https://lnkd.in/emDTQTjj #IPF #pulmonaryfibrosis #fibroticlungdisease #respiratorymedicine
About us
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.
- Website
-
https://fortrea.com
External link for Fortrea
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Research Triangle Park, NC
- Type
- Public Company
Locations
-
Primary
Research Triangle Park, NC, US
Employees at Fortrea
-
Alan Switzer
Clinical systems and process specialist | Digital transformation expert | Collaborative partner | Client Engagement Leader at Fortrea.
-
Linda Watkins
I have finally found my professional home!
-
Miroslaw (Mirek) Dudek
Associate Director, Change Management at Fortrea
-
Robert Boman
Global Creative Director | Team Builder | Omni-channel Storyteller | BBQ Snob
Updates
-
We’re committed to bringing clinical research to all. We seek to enable greater patient access, promoting diversity and inclusion, building trust and true partnerships with sites. We are Fortrea. www.fortrea.com #teamfortrea #CRO #clinicalresearch #clinicaldevelopment #patientaccess
-
New joint Fortrea and Labcorp research finds younger #lungcancer patients have different genetic and immune system profiles than older patients. This study, including both men and women, suggests treatment strategies may need to be tailored based on age and gender for better outcomes. Learn more: https://lnkd.in/eaXi-J8H #personalizedmedicine
-
1 in 8 Black and African Americans are at risk for APOL1-mediated kidney disease. To address the disparity of kidney disease in Black Americans, reduce kidney failure and advance research, Fortrea’s Dr. Barbara Gillespie is heading to Capitol Hill. As part of “Rare Kidneys on the Hill Day” with NephCure, she’ll be joining advocates and engaging with Congress to make a difference for patients. #NephCureHillDay2024 #KidneyDisease #BlackHealthMatters #HealthEquity #RareDiseaseAdvocacy #CapitolHill
-
Combined Advanced Therapy Medicinal Products (CATMPs) hold immense promise for patients, but navigating their development can be complex due to unique regulatory requirements. Our latest blog dives into the challenges and opportunities surrounding CATMPs in Europe. We explore the current regulatory landscape and how it's evolving to support this innovative field. https://lnkd.in/eMVP86FR
-
Trust Fortrea to handle the complexities of your clinical pharmacology needs. Find out how we can help you gain critical data to make earlier and more confident decisions. Want to watch the full video? https://lnkd.in/eFRYwHNP #clinicaltrials #research #Leeds #Fortrea
-
Fortrea Nominated for 2024 SCRS Eagle Award: Vote for Streamlined Trials! At Fortrea, we’re on a mission to simplify clinical trials. We achieve this by collaborating closely with our valued site partners, clinicians and investigators right from the start. Their early input allows us to: • Design stronger protocols: By incorporating their expertise, we ensure trials are achievable and relevant. • Simplify workflows: We streamline processes to minimize complexity and maximize efficiency. • Get sites up and running faster: Early collaboration means sites can hit the ground running when the trial begins. This commitment to streamlining trials has earned Fortrea a nomination for the prestigious SCRS Eagle Award, recognizing sponsors dedicated to exceptional site partnerships. We would be incredibly grateful if you would take a moment to vote for Fortrea. Your vote helps us continue building stronger partnerships and smoother trials! https://lnkd.in/dh_HS9U6 Voting closes on July 31. Thank you! #SCRSeagleaward #clinicalresearchsites #ClinicalTrials #SitePartnerships
-
Our flagship CRU covers all major first-in-human and registrational package study types! Want to watch the full video? https://lnkd.in/eFRYwHNP #clinicaltrials #research #Leeds #Fortrea
-
Fortrea Market Access Consulting & HEOR helps prepare you to demonstrate the full value of your product to payers, regulators and other audiences, and advises on pathways to gain reimbursement and access. Our consultants provide integrated solutions to support your product through development and commercialization. Want to learn more? https://lnkd.in/ems-ZRd5 #marketaccess #HEOR #RWE #valuedemonstration
-
Once checked in, our spacious facility has plenty of activities and comforts to make each participant’s stay a pleasant one such as reading rooms, a cinema, and a controlled, secure outdoor space on the roof of the building. Want to watch the full video? https://lnkd.in/eFRYwHNP #clinicaltrials #research #Leeds #Fortrea